Results 71 to 80 of about 3,221 (136)

Indoleamine-pyrrole 2,3-dioxygenase (INDO; IDO) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Diversity and conservation of interactions for binding heme in b-type heme proteins [PDF]

, 2007
Marles-Wright, Jon, Paoli, Max, Schneider, Sabine, Sharp, Katherine H   +3 more
core   +1 more source

Indoleamine-pyrrole 2,3 dioxygenase (IDO1; INDO; IDO) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Indoleamine-pyrrole 2,3-dioxygenase (INDO); histone deacetylase (HDAC) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Influence of commonly used pharmaceutical agents on equine bone marrow-derived mesenchymal stem cell viability [PDF]

, 2017
Ankrum, Becerra, Bohannon, Broeckx, Chang, Distelhorst, Donega, Dregalla, Ferris, Fredriksson, Frisbie, Garcia-Villar, Garvican, Godwin, Guest, Guest, Hammer, Keegan, McIlwraith, Müller, Nagy, Parker, Qiu, Salonen, Smith, Smith, Sole, Sole, Strober, Tan, Wilke, Wyles, Zhang   +32 more
core   +2 more sources

Indoleamine 2,3-Dioxygenase: A Potential Biomarker for Neural Damage Severity of Leprosy Neuropathy. [PDF]

Cell Mol Neurobiol
Rahman AU, Santana RC, de Pinho Pereira MM, Moura CLS, de Oliveira JAP, Sarno EN, da Silva GMS, Jardim MR, Pinheiro RO.   +8 more
europepmc   +1 more source

Development of a Fluorophore-Bound l-Tryptophan Derivative for Evaluating Indoleamine 2,3-Dioxygenase Activity by HPLC with Fluorescence Detection: An In Vivo Microdialysis Study Using Rat Kidney. [PDF]

Molecules
Onozato M, Aoki R, Yamaguchi M, Fujimoto H, Sakamoto T, Fukushima T.   +5 more
europepmc   +1 more source

Targeting Overexpressed IDO in Stromal Cells as a Potential Therapeutic Strategy in Multiple Myeloma. [PDF]

Cancer Sci
Ebina T, Ri M, Marumo Y, Nakamura T, Sasaki H, Oshima Y, Nakashima T, Hagiwara S, Asano A, Kinoshita S, Suzuki T, Narita T, Masaki A, Sanda T, Yamagata K, Kubo K, Komatsu H, Sakuraba H, Iida S.   +18 more
europepmc   +1 more source

Immunostimulatory and Immunodynamic Modeling Analysis to Determine a Plausible Starting Dose of mRNA-4359 for Use in First-In-Human Trials. [PDF]

CPT Pharmacometrics Syst Pharmacol
Greene SA, Channavazzala M, Paleja B, Sandhu HS, Kumar R, Attarwala H, Van L, Liang M.   +7 more
europepmc   +1 more source

Piperine suppresses M1 phenotype and induces indoleamine 2,3-dioxygenase gene in LPS-stimulated murine macrophage cell line. [PDF]

BMC Res Notes
Gholijani N, Dehghan Z, Abolmaali SS, Talepoor AG, Kalantar K, Daryabor G.   +5 more
europepmc   +1 more source